|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.85 EUR | -0.25% |
|
-0.75% | +13.43% |
| Feb. 26 | Dr. Hönle AG Reports Earnings Results for the First Quarter Ended December 31, 2023 | CI |
| Jan. 25 | Dr. Hönle AG Reports Earnings Results for the Full Year Ended September 30, 2023 | CI |
Dr. Hönle AG reported earnings results for the full year ended September 30, 2022. For the full year, the company reported sales was EUR 126.91 million compared to EUR 115.22 million a year ago. Net loss was EUR 13.36 million compared to EUR 4.82 million a year ago.
Basic loss per share from continuing operations was EUR 2.2 compared to EUR 0.8 a year ago. Diluted loss per share from continuing operations was EUR 2.2 compared to EUR 0.8 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +13.43% | 129M | |
| +12.62% | 82.74B | |
| +17.86% | 69.97B | |
| +20.14% | 37.66B | |
| +14.52% | 31.6B | |
| +12.80% | 27.79B | |
| +2.46% | 26.5B | |
| +15.42% | 25.66B | |
| +2.11% | 25.43B | |
| +15.63% | 24.64B |
DR. HÖNLE AG 
